# A Clinical Trial to Assess the Effect of HC-SVT-1001 and HC-SVT-1002 in the Surgical Treatment of Atrophic Pseudarthrosis of Long Bones (Bonecure)

> **NCT02483364** · PHASE2 · COMPLETED · sponsor: **Salvat** · enrollment: 12 (actual)

## Conditions studied

- Pseudoarthrosis

## Interventions

- **OTHER:** HC-SVT-1001(initial protocol); HC-SVT-1002 (protocol amendment)

## Key facts

- **NCT ID:** NCT02483364
- **Lead sponsor:** Salvat
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11-10
- **Primary completion:** 2020-05-18
- **Final completion:** 2020-10-20
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2021-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02483364

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02483364, "A Clinical Trial to Assess the Effect of HC-SVT-1001 and HC-SVT-1002 in the Surgical Treatment of Atrophic Pseudarthrosis of Long Bones (Bonecure)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02483364. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*